TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 28 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $183,000 | +60.5% | 10,380 | -12.2% | 0.00% | – |
Q2 2021 | $114,000 | +4.6% | 11,819 | +16.5% | 0.00% | – |
Q1 2021 | $109,000 | +6.9% | 10,143 | +45.4% | 0.00% | – |
Q4 2020 | $102,000 | +1357.1% | 6,978 | +1295.6% | 0.00% | – |
Q3 2020 | $7,000 | +40.0% | 500 | -26.9% | 0.00% | – |
Q2 2020 | $5,000 | +150.0% | 684 | +31.3% | 0.00% | – |
Q1 2020 | $2,000 | +100.0% | 521 | +2.6% | 0.00% | – |
Q4 2019 | $1,000 | – | 508 | -26.9% | 0.00% | – |
Q3 2019 | $0 | – | 695 | +382.6% | 0.00% | – |
Q2 2019 | $0 | – | 144 | -37.4% | 0.00% | – |
Q1 2019 | $0 | – | 230 | +945.5% | 0.00% | – |
Q3 2018 | $0 | – | 22 | +37.5% | 0.00% | – |
Q2 2018 | $0 | -100.0% | 16 | -81.6% | 0.00% | – |
Q1 2018 | $1,000 | – | 87 | +55.4% | 0.00% | – |
Q4 2017 | $0 | – | 56 | +366.7% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 12 | -81.0% | 0.00% | – |
Q3 2016 | $1,000 | – | 63 | +26.0% | 0.00% | – |
Q2 2016 | $0 | – | 50 | +31.6% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 38 | -13.6% | 0.00% | – |
Q3 2015 | $1,000 | -50.0% | 44 | -61.7% | 0.00% | – |
Q2 2015 | $2,000 | – | 115 | +1816.7% | 0.00% | – |
Q4 2014 | $0 | – | 6 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|